History of kidney stones and the risk of coronary heart disease

JAMA

Volumn 310, Issue 4, 2013, Pages 408-415

  Ferraro, Pietro Manuel ^a,b   Taylor, Eric N ^b   Eisner, Brian H ^c   Gambaro, Giovanni ^a   Rimm, Eric B ^b   Mukamal, Kenneth J ^d   Curhan, Gary C ^b  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY RISK; DISEASE ASSOCIATION; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NEPHROLITHIASIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT;

EID: 84880399471     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.8780     Document Type: Article

References (42)

1. Scales CD Jr, Smith AC, Hanley JM, Saigal CS; Urologic Diseases in America Project. Prevalence of kidney stones in the United States. Eur Urol. 2012;62(1):160-165.
2. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003;63(5):1817-1823. (Pubitemid 36513328)
3. Reiner AP, Kahn A, Eisner BH, et al. Kidney stones and subclinical atherosclerosis in young adults: the CARDIA study. J Urol. 2011;185(3):920-925.
4. Madore F, Stampfer MJ, Willett WC, Speizer FE, Curhan GC. Nephrolithiasis and risk of hypertension in women. Am J Kidney Dis. 1998;32(5):802-807. (Pubitemid 28516311)
5. Borghi L, Meschi T, Guerra A, et al. Essential arterial hypertension and stone disease. Kidney Int. 1999;55(6):2397-2406. (Pubitemid 29256494)
6. Gillen DL, Coe FL, Worcester EM. Nephrolithiasis and increased blood pressure among females with high body mass index. Am J Kidney Dis. 2005;46(2):263-269. (Pubitemid 41040354)
7. Taylor EN, Stampfer MJ, Curhan GC. Diabetes mellitus and the risk of nephrolithiasis. Kidney Int. 2005;68(3):1230-1235. (Pubitemid 43246441)
8. Chung SD, Chen YK, Lin HC. Increased risk of diabetes in patients with urinary calculi: a 5-year follow-up study. J Urol. 2011;186(5):1888-1893.
9. West B, Luke A, Durazo-Arvizu RA, Cao G, Shoham D, Kramer H. Metabolic syndrome and self-reported history of kidney stones: the National Health and Nutrition Examination Survey (NHANES III) 1988-1994. Am J Kidney Dis. 2008;51(5):741-747. (Pubitemid 351626247)
10. Domingos F, Serra A. Nephrolithiasis is associated with an increased prevalence of cardiovascular disease. Nephrol Dial Transplant. 2011;26(3):864-868.
11. Elmfeldt D, Vedin A, Wilhelmsson C, Tibblin G, Wilhelmsen L. Morbidity in representative male survivors of myocardial infarction compared to representative population samples. J Chronic Dis. 1976;29(4):221-231.
12. Hamano S, Nakatsu H, Suzuki N, Tomioka S, Tanaka M, Murakami S. Kidney stone disease and risk factors for coronary heart disease. Int J Urol. 2005;12(10):859-863. (Pubitemid 41726955)
13. Rule AD, Roger VL, Melton LJ III, et al. Kidney stones associate with increased risk for myocardial infarction. J Am Soc Nephrol. 2010;21(10):1641- 1644.
14. Alexander RT, Hemmelgarn BR, Wiebe N, et al Alberta Kidney Disease Network. Kidney stones and kidney function loss: a cohort study. BMJ. 2012;345:e5287.
15. Yasui T, Fujita K, Hayashi Y, et al. Quantification of osteopontin in the urine of healthy and stone-forming men. Urol Res. 1999;27(4):225-230. (Pubitemid 29431736)
16. Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328(12):833-838. (Pubitemid 23084337)
17. Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med. 1997;126(7):497-504. (Pubitemid 27143627)
18. Rimm EB, Giovannucci EL, Willett WC, et al. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet. 1991;338(8765):464-468.
19. Rimm EB, Giovannucci EL, Stampfer MJ, Colditz GA, Litin LB, Willett WC. Reproducibility and validity of an expanded self-administered semiquantitative food frequency questionnaire among male health professionals. Am J Epidemiol. 1992;135(10):1114-1126.
20. Feskanich D, Rimm EB, Giovannucci EL, et al. Reproducibility and validity of food intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc. 1993;93(7):790-796. (Pubitemid 23260170)
21. Centers for Disease Control and Prevention. National Vital Statistics Report, Vol. 59, No. 10: Table I-7: Number of deaths, death rates, and age-adjusted death rates for ages 15 years and over, by marital status and sex: United States, 2008. http://www.cdc.gov/nchs/data/nvsr/nvsr59/nvsr59-10-tables. pdf. Accessed June 24, 2013.
22. Taylor EN, Fung TT, Curhan GC. DASH-style diet associates with reduced risk for kidney stones. J Am Soc Nephrol. 2009;20(10):2253-2259.
23. Fung TT, Chiuve SE, McCullough ML, Rexrode KM, Logroscino G, Hu FB. Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women. Arch Intern Med. 2008;168(7):713-720. (Pubitemid 351563954)
24. Westlund K. Urolithiasis and coronary heart disease: a note on association. Am J Epidemiol. 1973;97(3):167-172.
25. Ljunghall S, Hedstrand H. Renal stones and coronary heart disease. Acta Med Scand. 1976;199(6):481-485.
26. Aydin H, Yencilek F, Erihan IB, Okan B, Sarica K. Increased 10-year cardiovascular disease and mortality risk scores in asymptomatic patients with calcium oxalate urolithiasis. Urol Res. 2011;39(6):451-458.
27. Wang L, Manson JE, Sesso HD. Calcium intake and risk of cardiovascular disease: a review of prospective studies and randomized clinical trials. Am J Cardiovasc Drugs. 2012;12(2):105-116.
28. Reilly RF, Peixoto AJ, Desir GV. The evidence-based use of thiazide diuretics in hypertension and nephrolithiasis. Clin J Am Soc Nephrol. 2010;5(10):1893-1903.
29. Ando R, Suzuki S, Nagaya T, et al. Impact of insulin resistance, insulin and adiponectin on kidney stones in the Japanese population. Int J Urol. 2011;18(2):131-138.
30. Cirillo M, Laurenzi M. Elevated blood pressure and positive history of kidney stones: results from a population-based study. J Hypertens Suppl. 1988;6(4):S485-S486. (Pubitemid 19067382)
31. Cappuccio FP, Strazzullo P, Mancini M. Kidney stones and hypertension: population based study of an independent clinical association. BMJ. 1990;300(6734):1234-1236. (Pubitemid 20170675)
32. Rendina D, Mossetti G, De Filippo G, et al. Association between metabolic syndrome and nephrolithiasis in an inpatient population in southern Italy: role of gender, hypertension and abdominal obesity. Nephrol Dial Transplant. 2009;24(3):900-906.
33. Jeong IG, Kang T, Bang JK, et al. Association between metabolic syndrome and the presence of kidney stones in a screened population. Am J Kidney Dis. 2011;58(3):383-388.
34. Curhan GC, Willett WC, Knight EL, Stampfer MJ. Dietary factors and the risk of incident kidney stones in younger women: Nurses' Health Study II. Arch Intern Med. 2004;164(8):885-891. (Pubitemid 38520630)
35. McCarron DA, Morris CD, Stanton JL. Hypertension and calcium. Science. 1984;226(4673):386-393.
36. Rule AD, Krambeck AE, Lieske JC. Chronic kidney disease in kidney stone formers. Clin J Am Soc Nephrol. 2011;6(8):2069-2075.
37. Hippisley-Cox J, Coupland C. Predicting the risk of chronic kidney disease in men and women in England and Wales: prospective derivation and external validation of the QKidney Scores. BMC Fam Pract. 2010;11:49-61.
38. US Renal Data System. USRDS 2010 Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United States. http://www.usrds.org/2010/view/. Accessed June 24, 2013.
39. Ohmori R, Momiyama Y, Taniguchi H, et al. Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis. 2003;170(2):333-337. (Pubitemid 37377807)
40. Wesson JA, Johnson RJ, Mazzali M, et al. Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules. J Am Soc Nephrol. 2003;14(1):139-147. (Pubitemid 36026305)
41. Kleinman JG, Wesson JA, Hughes J. Osteopontin and calcium stone formation. Nephron Physiol. 2004;98(2):43-47.
42. Stoller ML, Meng MV, Abrahams HM, Kane JP. The primary stone event: a new hypothesis involving a vascular etiology. J Urol. 2004;171(5):1920-1924. (Pubitemid 38501044)